Avalo Therapeutics Inc (AVTX) — Cash Flow Reinvestment Rate

Latest as of September 2022: 0.01x

Avalo Therapeutics Inc (AVTX) has a Cash Flow Reinvestment Rate of 0.01x as of September 2022, reinvesting $78.00K (capex $39.00K plus investments $-39.00K) from operating cash flow of $5.73 Million. Check Avalo Therapeutics Inc (AVTX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

$78.00K

Capex + Investments

Operating Cash Flow

$5.73 Million

USD

Capital Expenditures

$39.00K

USD

Avalo Therapeutics Inc Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for Avalo Therapeutics Inc across 1 annual periods. Explore how well can Avalo Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Avalo Therapeutics Inc (2017–2017)

Year-by-year capital reinvestment analysis for Avalo Therapeutics Inc. For live market cap and broader valuation context, see how much is Avalo Therapeutics Inc worth.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2017	1.03x	$12.86 Million	$12.52 Million	$23.32K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow